M1 KLINIKEN AG O.N./ DE000A0STSQ8 /
| 2024-10-09 5:36:20 PM | Chg. +0.600 | Volume | Bid5:36:33 PM | Ask5:36:20 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 16.400EUR | +3.80% | 9,547 Turnover: 153,820.950 |
-Bid Size: - | -Ask Size: - | 314.29 mill.EUR | 3.13% | 29.63 |
Business description
The M1 Kliniken AG is one of the most important healthcare provider in Germany. The company offers plastic and cosmetic surgery treatments and management services for medical practices. In addition, the M1 Kliniken AG sells pharmaceuticals and medicinal products for aesthetic surgeries.
Management board & Supervisory board
| CEO |
|---|
| Attila Stauss |
| Management board |
| - |
| Supervisory board |
| Uwe Zimdars, Prof. Dr. med. Dirk Hempel, Prof. Dr. Dr. Sabine Meck |
Company data
| Name: | M1 Kliniken AG |
| Address: | Grünauer Straße 5,D-12557 Berlin |
| Phone: | +49-30-347-4744-14 |
| Fax: | - |
| E-mail: | info@m1-kliniken.de |
| Internet: | www.m1-kliniken.ag |
| Industry: | Healthcare |
| Sector: | Healthcare Providers |
| Sub sector: | Healthcare Providers |
| End of financial year: | 12-31 |
| Free Float: | - |
| IPO date: | 2015-09-14 |
Investor relations
| Name: | - |
| IR phone: | - |
| IR Fax: | - |
| IR e-mail: | ir@m1-kliniken.de |
Company calendar
| CW 47 | 2024-11-19 Interim Report 3rd Quarter/9 Months |
Main Shareholders
| Others | 87.33% | |
| HAEMATO AG | 7.16% | |
| Natixis Investment Managers International | 2.16% | |
| Paladin Asset Management GmbH | 1.23% | |
| Baring Asset Management Limited | 0.83% | |
| Norges Bank Investment Management | 0.38% | |
| FPM Frankfurt Performance Management AG | 0.38% | |
| Fosun International Holdings Ltd. | 0.35% | |
| Velten Asset Management GmbH | 0.10% | |
| Others | 0.09% |
